Catalyst Wire Dossier Catalyst Wire Dossier

LPCN 1021

· Lipocine Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LPCN 1021, covering 2017-10-23 to 2017-10-23. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism [Phase 3]

See pricing